- Home
- NVRO vs RVMDW Comparison
NVRO vs RVMDW Comparison
Compare NVRO & RVMDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVRO
- RVMDW
- Stock Information
- Founded
- NVRO 2006
- RVMDW N/A
- Country
- NVRO United States
- RVMDW United States
- Employees
- NVRO N/A
- RVMDW 490
- Industry
- NVRO Medical/Dental Instruments
- RVMDW
- Sector
- NVRO Health Care
- RVMDW
- Exchange
- NVRO Nasdaq
- RVMDW Nasdaq
- Market Cap
- NVRO 134.5M
- RVMDW N/A
- IPO Year
- NVRO 2014
- RVMDW N/A
- Fundamental
- Price
- NVRO $3.71
- RVMDW $0.18
- Analyst Decision
- NVRO Hold
- RVMDW
- Analyst Count
- NVRO 14
- RVMDW 0
- Target Price
- NVRO $7.97
- RVMDW N/A
- AVG Volume (30 Days)
- NVRO 395.4K
- RVMDW N/A
- Earning Date
- NVRO 02-19-2025
- RVMDW N/A
- Dividend Yield
- NVRO N/A
- RVMDW N/A
- EPS Growth
- NVRO N/A
- RVMDW N/A
- EPS
- NVRO N/A
- RVMDW N/A
- Revenue
- NVRO $419,146,000.00
- RVMDW N/A
- Revenue This Year
- NVRO N/A
- RVMDW N/A
- Revenue Next Year
- NVRO $0.65
- RVMDW N/A
- P/E Ratio
- NVRO N/A
- RVMDW N/A
- Revenue Growth
- NVRO N/A
- RVMDW N/A
- 52 Week Low
- NVRO $3.52
- RVMDW N/A
- 52 Week High
- NVRO $21.66
- RVMDW N/A
- Technical
- Relative Strength Index (RSI)
- NVRO 43.89
- RVMDW N/A
- Support Level
- NVRO $3.60
- RVMDW N/A
- Resistance Level
- NVRO $3.90
- RVMDW N/A
- Average True Range (ATR)
- NVRO 0.28
- RVMDW 0.00
- MACD
- NVRO 0.01
- RVMDW 0.00
- Stochastic Oscillator
- NVRO 39.56
- RVMDW 0.00
About NVRO Nevro Corp.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
About RVMDW Revolution Medicines Inc. Warrant
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.